OTRK - Ontrak, Inc. Stock Analysis | Stock Taper
Logo
Ontrak, Inc.

OTRK

Ontrak, Inc. NASDAQ
$0.33 358.19% (+0.26)

Market Cap $2.34 M
52w High $5.53
52w Low $0.01
P/E -0.02
Volume 258.32K
Outstanding Shares 7.08M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q1-2025 $2.02M $6.6M $-6.89M -341.65% $-1.65 $-5.29M
Q4-2024 $3.15M $6.28M $-5.16M -164.08% $-9.54 $-4.04M
Q3-2024 $2.57M $6.7M $-5.58M -217.21% $-1.77 $-4.93M
Q2-2024 $2.45M $5.65M $-10.29M -419.79% $-2.84 $-9.64M
Q1-2024 $2.68M $5.39M $-4.46M -166.34% $-1.65 $-3.98M

What's going well?

The company is still investing in research and development, which could pay off if new products succeed. No one-time charges mean the results are a clear picture of ongoing operations.

What's concerning?

Sales dropped sharply while expenses kept rising, leading to bigger losses. High interest costs and heavy overhead make it hard to see a path to profit unless revenue rebounds fast.

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q1-2025 $4.09M $18.27M $13.62M $4.65M
Q4-2024 $5.71M $21.07M $11.21M $9.87M
Q3-2024 $7.97M $22.4M $10.94M $11.46M
Q2-2024 $7.29M $25.27M $9.86M $15.41M
Q1-2024 $6.4M $26.72M $5.48M $21.25M

What's financially strong about this company?

They still have positive equity and some cash on hand. No major off-balance-sheet or unusual liabilities are visible.

What are the financial risks or weaknesses?

Cash is dropping quickly, short-term debt is high, and the company is relying on stretching payables. Equity has been cut in half in just one quarter, and there are large accumulated losses.

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q1-2025 $-6.89M $-2.72M $-58K $1.16M $-1.62M $-2.78M
Q4-2024 $-5.16M $-4.29M $-75K $2.11M $-2.26M $-4.37M
Q3-2024 $-5.58M $-1.41M $-28K $2.11M $674K $-1.44M
Q2-2024 $-10.29M $-4.47M $-37K $5.4M $892K $-4.51M
Q1-2024 $-4.46M $-3.26M $-37K $-5K $-3.3M $-3.3M

What's strong about this company's cash flow?

Cash burn is shrinking, with operating and free cash flow losses both improving compared to last quarter. Working capital changes gave a temporary boost to cash flow.

What are the cash flow concerns?

The company is still losing money and burning cash, with only $4.1 million left and no sign of self-sufficiency. It relies on borrowing to survive and will need more funding soon.

Revenue by Products

Product Q1-2014Q1-2019Q2-2019Q1-2025
Reportable Segment
Reportable Segment
$0 $0 $0 $0
Commercial
Commercial
$0 $0 $0 $0
Government Contract
Government Contract
$0 $0 $0 $0
Consolidated Continuing Operations
Consolidated Continuing Operations
$0 $0 $0 $0

Q1 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at Ontrak, Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Historically, Ontrak’s main strengths were its focused niche in high‑cost behavioral health populations, its AI‑enabled engagement technology, and a value‑based care model that aligned with payer interests. It was able to sign notable health plan partners, improve gross margins through cost control, and gradually reduce its cash burn. The flexible range of programs—from intensive care management to quality‑improvement tools—showed a thoughtful product strategy tailored to payer needs.

! Risks

The risk side was much heavier. Revenue collapsed after the loss of key customers, and large net losses persisted even as the company cut spending. Cash reserves dwindled, leverage became more concerning, and liquidity metrics deteriorated. Strategically, the business was exposed to intense competition from much larger digital health players, long and uncertain sales cycles, and high customer concentration. These financial and competitive pressures ultimately led Ontrak to cease operations and file for Chapter 7 bankruptcy.

Outlook

With a Chapter 7 filing and operations discontinued, Ontrak is no longer an ongoing concern; the focus shifts to liquidating assets rather than executing a turnaround. Looking back, the company combined compelling healthcare innovation with a fragile financial and competitive foundation. Any similar model in the future would need stronger diversification, more stable funding, and clearer line of sight to sustainable positive cash flow to avoid the same outcome.